Y, S., T, C., J, L., L, Z., Q, M., L, F., & H, Z. (2026). BRAF inhibitor resistance in melanoma: From resistance mechanisms to therapeutic innovations. Molecular biomedicine, 7(1), . https://doi.org/10.1186/s43556-026-00425-4
Chicago Style (17th ed.) CitationY, Shang, Cao T, Li J, Zhang L, Ma Q, Feng L, and Zhao H. "BRAF Inhibitor Resistance in Melanoma: From Resistance Mechanisms to Therapeutic Innovations." Molecular Biomedicine 7, no. 1 (2026). https://doi.org/10.1186/s43556-026-00425-4.
MLA (9th ed.) CitationY, Shang, et al. "BRAF Inhibitor Resistance in Melanoma: From Resistance Mechanisms to Therapeutic Innovations." Molecular Biomedicine, vol. 7, no. 1, 2026, https://doi.org/10.1186/s43556-026-00425-4.
Warning: These citations may not always be 100% accurate.